ASP Isotopes Inc. Announces Capital Markets Day and 8‑K Filing
ASP Isotopes Inc. (NASDAQ: ASPI) confirmed on July 28, 2026 that it will host a Capital Markets Day in London on September 8, 2026. The event, scheduled to begin at 10:00 a.m. ET (3:00 p.m. BST), will be followed by a formal question‑and‑answer session until 12:30 p.m. ET (5:30 p.m. BST). While attendance in London is by invitation, the company will stream the presentation live and make the materials available on its investor‑relations website. A replay will be posted after the event.
The agenda focuses on ASP Isotopes’ strategic direction and commercial momentum. Executives will outline progress in three key markets:
| Market | Focus Area |
|---|---|
| Nuclear medicine | Enrichment of short‑lived isotopes for imaging and therapy |
| Electronic gases | Production of high‑purity gases for next‑generation semiconductor fabrication |
| Nuclear fuels | Development of light‑isotope fuels for advanced reactors |
ASP Isotopes’ proprietary technologies—Aerodynamic Separation Process (ASP technology) and Quantum Enrichment (QE technology)—are designed to streamline isotope production, potentially reducing cost and improving supply‑chain resilience for critical materials.
8‑K Disclosure
On the same day, ASP Isotopes filed a Form 8‑K current report with the U.S. Securities and Exchange Commission. The filing provides details about the forthcoming Capital Markets Day and reiterates the company’s commitment to transparency regarding its strategic initiatives and partnership activities.
Context: Proposed Transactions with ENDRA Life Sciences
The 8‑K and press release also reference the proposed merger involving ENDRA Life Sciences Inc., ASP Isotopes, and several of its subsidiaries—Renergen and Noble Africa. ENDRA intends to file a Form S‑4 registration statement with the SEC, which will include a proxy statement and prospectus outlining the terms of the proposed transaction. Shareholders of ENDRA are encouraged to review these documents, which will become available through the SEC’s public portal.
Company Snapshot
- Sector: Materials
- Primary Exchange: Nasdaq
- Market Capitalization: $620.9 million (USD)
- Stock Price (27 Jul 2026): $3.775
- 52‑Week Range: $3.61 – $14.49
- Price‑to‑Earnings Ratio: –2.76
ASP Isotopes remains in the pre‑commercial stage, focusing on high‑value, low‑volume isotope production for medical, nuclear power, and other advanced industries worldwide. The Capital Markets Day is positioned as a milestone event to showcase the company’s technological advancements, market opportunities, and the strategic rationale behind its potential partnership with ENDRA Life Sciences.
